Macrogen, Inc. (KOSDAQ:038290)
18,650
+590 (3.27%)
Feb 19, 2026, 12:30 PM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 195.8 billion as of February 18, 2026. Its market cap has increased by 15.62% in one year.
Market Cap
195.80B
Enterprise Value
272.58B
Revenue
179.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
18,650.00
Market Cap Chart
Since September 14, 2000, Macrogen's market cap has increased from 148.29B to 195.80B, an increase of 32.04%. That is a compound annual growth rate of 1.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 195.80B | 7.05% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JETEMA, | 353.23B |
| Bioneer | 332.44B |
| Helixmith | 310.82B |
| EASY BIO,Inc. | 250.10B |
| HLB Therapeutics | 240.96B |
| Genexine | 201.02B |
| MedPacto | 200.85B |
| ENCell | 183.11B |